Webinar of the Month
Discovery and characterization of miRNAs expressed in cancers
By Dr. Veena Hedatale
Senior Application Scientist - Avadis NGS, Strand Life Sciences
miRNAs constitute a family of small RNA species that function as important regulators of cellular processes by modulating gene expression. In this webinar, we will focus on miRNA analysis using next generation sequencing cancer data with insights to alignment, quality checks, filtering and analysis steps. Using the small RNA workflow in Avadis NGS, users can rapidly and easily characterize miRNA expression and function by expression profiling, identification of sequence isoforms, prediction of novel miRNAs, and prediction of potential mRNA target molecules.
Updates
Pleased to share the release of Avadis NGS version 1.6. Key highlights of the latest version includes longer indel detection, new workflow step for identification of somatic mutations, local realignment step optimized for speed, multiple usability enhancements on views and utilities and many more. For details refer to the release notes
Catch us at the 2014 ACMG Annual Clinical Genetics Meeting to be held in Nashville, Tenessee from 26- 29 March 2014. Visit our booth #931 and meet our experts to learn about the latest features of Avadis NGS and how it is now being used in a clinical genomics pipeline to process hundreds of samples
Visit our booth #1628 at the SOT 2014, 53rd Annual meeting of the Society of Toxicology at Phoenix, Arizona from 23- 27 March, 2014. Strand also presents 3 posters at the event
- Poster 1: 'Using In Silico Modeling to Understand the Role of BSO in GSH Metabolism' by Dr. Sonali Das
- Poster 2: 'An Analysis of the Toxicity of Ximelagatran Using a Combination of In Vitro and In Silico Methods' by Dr. Amit Khanna
- Poster 3: 'Understanding the Differences in the Toxicity of Tolcapone and Entacapone: A Comparative Study Using the Virtual Liver Platform - Heptox' by Mr. Rajeev Kumar
Read the latest blog on 'Mapping RefSeq transcripts to the genome using UCSC' by Dr. Vamsi Veeramachaneni
The Avadis NGS Team
|
 |
| Session 1:
|
| Europe +Asia
|
| Mar 26, 2014 |
| 10 AM Central European Time |
| Session 2:
|
| North + South America |
| Mar 26, 2014 |
| 9 AM Pacific Standard Time |
| Confirm your participation on or before 26th Mar 2014, 10:00 AM IST by Registering here |
|
This message was sent to you by Strand Scientific Intelligence, Inc.
548 Market Street, Suite 82804, San Francisco, CA 94104, www.strandsi.com.
Avadis is a registered trademark of Strand Life Sciences Private
Limited. You have received this email because you have opted in to
receive messages regarding Avadis NGS. You may click here to unsubscribe if you don't want to receive emails from Strand Scientific Intelligence, Inc.
